Latest filing published 11 Oct 2024 for Cocrystal Pharma, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anthony J. Japour has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Opko Health, Inc. and Cocrystal Pharma, Inc. In total, 3 filings cover trades dated from 3 March 2020 to 9 October 2024.
Purchases make up the whole of the open-market record (2 purchases, €1,330). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
On 11 October 2024 came the latest disclosure, a share grant in Cocrystal Pharma, Inc. The last purchase on record was published on 13 March 2020, which is 2,415 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations